Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.

Autor: Aggarwal A; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Stella AO; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Walker G; Serology and Virology Division (SAViD), NSW Health Pathology, Sydney, New South Wales, Australia., Akerman A; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Esneau C; Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia., Milogiannakis V; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Burnett DL; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., McAllery S; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Silva MR; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Lu Y; Serology and Virology Division (SAViD), NSW Health Pathology, Sydney, New South Wales, Australia., Foster CSP; Serology and Virology Division (SAViD), NSW Health Pathology, Sydney, New South Wales, Australia., Brilot F; Brain Autoimmunity Group, Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, School of Medical Sciences, Sydney University of Sydney, Sydney Institute for Infectious Diseases, Sydney, New South Wales, Australia., Pillay A; Brain Autoimmunity Group, Kids Neuroscience Centre, The Children's Hospital at Westmead, Faculty of Medicine and Health, School of Medical Sciences, Sydney University of Sydney, Sydney Institute for Infectious Diseases, Sydney, New South Wales, Australia., Van Hal S; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Mathivanan V; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Fichter C; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Kindinger A; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Hoppe AC; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Munier ML; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Amatayakul-Chantler S; Department of Bioanalytical Sciences, Plasma Product Development, Research and Development, CSL Behring, Broadmeadows, Melbourne, Victoria, Australia., Roth N; Department of Bioanalytical Sciences, Plasma Product Development, Research and Development, CSL Behring AG, Bern, Switzerland., Coppola G; Department of Bioanalytical Sciences, Plasma Product Development, Research and Development, CSL Behring, Broadmeadows, Melbourne, Victoria, Australia., Symonds GP; Gene Therapy Research, Sydney, New South Wales, Australia., Schofield P; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Jackson J; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Lenthall H; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Henry JY; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Mazigi O; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Jäck HM; University of Erlangen-Nürnberg, Erlangen, Germany., Davenport MP; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Darley DR; St Vincent's Hospital, Sydney, New South Wales, Australia., Matthews GV; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.; St Vincent's Hospital, Sydney, New South Wales, Australia., Khoury DS; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Cromer D; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Goodnow CC; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Christ D; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., Robosa R; Molecular Diagnostic Medicine Laboratory, Sydpath, St Vincent's Hospital, Sydney, New South Wales, Australia., Starck DJ; Molecular Diagnostic Medicine Laboratory, Sydpath, St Vincent's Hospital, Sydney, New South Wales, Australia., Bartlett NW; Serology and Virology Division (SAViD), NSW Health Pathology, Sydney, New South Wales, Australia., Rawlinson WD; Hunter Medical Research Institute, University of Newcastle, Callaghan, New South Wales, Australia., Kelleher AD; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.; St Vincent's Hospital, Sydney, New South Wales, Australia., Turville SG; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. sturville@kirby.unsw.edu.au.

Publikováno v: Nature microbiology [Nat Microbiol] 2022 Jun; Vol. 7 (6), pp. 896-908. Date of Electronic Publication: 2022 May 30.